Back
ProShares Ultra MSCI Brazil Capped Vs. Astrana Health Industry Stock Comparison
Sell
41
UBR
ProShares Ultra MSCI Brazil Capped
Last Price:
19.96
Seasonality Move:
2.6%
Sell
18
ASTH
Astrana Health
Last Price:
42.9200
Seasonality Move:
23.17%
Sell
41
ProShares Ultra MSCI Brazil Capped (UBR)
is a Sell
Is ProShares Ultra MSCI Brazil Capped a Buy, Sell or Hold?
- The current ProShares Ultra MSCI Brazil Capped [UBR] share price is $20.00. The Score for UBR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- UBR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Astrana Health (ASTH)
is a Sell
Is Astrana Health a Buy, Sell or Hold?
- The current Astrana Health [ASTH] share price is $46.8100. The Score for ASTH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- ASTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
UBR Stock Price Chart
What is ProShares Ultra MSCI Brazil Capped's stock price today?
-
The ProShares Ultra MSCI Brazil Capped share price today is $20.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UBR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASTH Stock Price Chart
What is Astrana Health's stock price today?
-
The Astrana Health share price today is $46.8100
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASTH is experiencing slight selling pressure.
UBR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 41.71 | Sell |
| Chaikin Money Flow: | 2918 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.12 - 21.36) | Sell |
| Bollinger Bands (100): | (20.61 - 23.81) | Sell |
ASTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.22 | Sell |
| Relative Strength Index (14 RSI): | 31.55 | Sell |
| Chaikin Money Flow: | -120939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.9492 - 60.3292) | Sell |
| Bollinger Bands (100): | (44.5893 - 56.9893) | Sell |
UBR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.16 | Sell |
| 20-day SMA: | 20.57 | Sell |
| 50-day SMA: | 21.99 | Sell |
| 200-day SMA: | 24.6 | Sell |
| 8-day EMA: | 20.31 | Sell |
| 20-day EMA: | 20.7 | Sell |
| 50-day EMA: | 21.58 | Sell |
| 200-day EMA: | 23.87 | Sell |
ASTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.86 | Sell |
| 20-day SMA: | 56.32 | Sell |
| 50-day SMA: | 55.22 | Sell |
| 200-day SMA: | 45.24 | Buy |
| 8-day EMA: | 52.97 | Sell |
| 20-day EMA: | 55 | Sell |
| 50-day EMA: | 54.44 | Sell |
| 200-day EMA: | 46.93 | Sell |
ProShares Ultra MSCI Brazil Capped Earnings Growth & UBR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astrana Health Earnings Growth & ASTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and a decrease next year of $0.13 per share.
ProShares Ultra MSCI Brazil Capped Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Astrana Health Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||